Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α.
Tezera LB, Bielecka MK, Ogongo P, Walker NF, Ellis M, Garay-Baquero DJ, Thomas K, Reichmann MT, Johnston DA, Wilkinson KA, Ahmed M, Jogai S, Jayasinghe SN, Wilkinson RJ, Mansour S, Thomas GJ, Ottensmeier CH, Leslie A, Elkington PT.
Tezera LB, et al. Among authors: reichmann mt.
Elife. 2020 Feb 24;9:e52668. doi: 10.7554/eLife.52668.
Elife. 2020.
PMID: 32091388
Free PMC article.